Practice Pearls

What can we help you find?
NETs
The panel of experts in the management of NETs review the indications and safety data of the somatostatin analogues.
nets
Megan May, PharmD, BCOP, and Daneng Li, MD, review the efficacy and the pivotal trials for the somatostatin analogues in the treatment of NETs.
NETs
Experts in the management of NETs discuss how the treatment landscape has evolved.
 
VTE
Paul Ament, PharmD, reviews the guidelines for the prevention of VTE.
VTE
A panel of experts share the ISTH recommendation and the pharmacist’s role in helping identify patients at increased risk of VTE.
VTE
Panelists review the tools, specifically the Padua and IMPROVE models used to identify VTE risks.
VTE
Paul Ament, PharmD, and Charles Mahan, PharmD, RPh, PhC, review the rates of VTE postdischarge from a hospital.
NETS
Megan May, PharmD, BCOP, and Daneng Li, MD, discuss when patients with NETs should be considered for active surveillance vs treatment.
VTE, thromboembolism, HSE
Experts in the management of VTE discuss the risks and risk factors for identifying VTE.
Thromboembolism
A panel of experts share how VTE therapy has evolved over time leading to its prevention in many cases.
VTE
Charles Mahan, PharmD, RPh, PhC, makes introductions, and Paul Ament, PharmD, provides an overview of venous thromboembolism [VTE].
Neuroendocrine Tumors
Cecilia Lau, RPh, BCOP, APh, provides a definition of neuroendocrine tumors, and Megan May, PharmD, BCOP, shares some of the diagnostic processes for NETs.